Event Brief
Mar 31, 2026 at 6:02 PM ET
High-dose vitamin B3 may slow aggressive brain cancer
By The BriefBrief
A study suggests high-dose vitamin B3 could enhance immune function and slow glioblastoma progression in patients.
WHO: Researchers at the University of Calgary
WHAT: Study on high-dose vitamin B3's effects on glioblastoma
WHEN: Mar 31, 2026 at 5:29 PM ET
WHERE: Canada
WHY: To determine if high-dose vitamin B3 can improve disease control in glioblastoma patients.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21417 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
